Unicycive Therapeutics (UNCY) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist

0.7898
+0.1196+17.85%

Close Dec 26 16:00 ET

0.7900
+0.0002+0.03%

Post 20:01 ET

85.63MMarket Cap-1.72P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics
GlobeNewswireDec 17 07:00 ET
Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY)
Yahoo FinanceNov 28 06:57 ET
Unicycive Therapeutics Price Target Maintained With a $3.00/Share by Benchmark
Dow JonesNov 22 09:49 ET · Ratings
Unicycive Therapeutics to Participate in Two Upcoming Investor Conferences Including a Fireside Chat at the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswireNov 21 07:00 ET
Maxim Group Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Announces Target Price $2
Moomoo NewsNov 14 12:32 ET · Ratings
Express News | Unicycive Therapeutics Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing
ReutersNov 13 17:30 ET

Comments

Tyler R Mills

Dec 18 14:49

$Unicycive Therapeutics (UNCY.US)$can we just see green for o ce! its been two weeks !!!!!!

Jaguar8

Dec 17 06:38

NEWS

$Unicycive Therapeutics (UNCY.US)$
Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics
Tuesday, 17th December at 7:00 am
LOS ALTOS, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the "Company" or "Unicycive"), today announced that data from the Company's oxylanthanum carbonate (OLC)...